Skip to content

Assessment of success rates & socio-economic impact of early endoscopic dacryocystorhinostomy surgery in acute dacryocystitis patients

Assessment of surgical success & socio-economic impact of early endoscopic vs delayed dacryocystorhinostomy surgery in acute dacryocystitis patients in tribal belts of west India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070953
Enrollment
150
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H043- Acute and unspecified inflammationof lacrimal passages Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Early Endonasal Endoscopic Dacryocystorhinostomy surgery: Endoscopic DCR surgery to be done within 7 days of presentation Control Intervention1: Delayed endoscopic endonasal Dacryocysto

Sponsors

Divyajyot eye trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with - 1. Age between 18 â?? 50 years at enrolment 2. Acute or subacute dacryocystitis at presentation 3. Roomy ipsilateral nasal cavity

Exclusion criteria

Exclusion criteria: All known cases of - 1. Coronary Artery Disease or cerebro-vascular disease patients on on anti-coagulation therapy, and patients of Bleeding disorders or coagulopathy 2. Ongoing Pregnancy or planning a pregnancy during follow-up period 3. Hypertension 4. Nasal pathologies like atrophic rhinitis, nasal polyps, turbinate hypertrophy, deviated nasal septum etc 5. Concurrent active upper respiratory tract infection, sinusitis, or orbital cellulitis 6. Prior failed external DCR or endonasal DCR 7. Concurrent punctal stenosis, proximal or distal canalicular block 8. Past history of nasal trauma, mucormycosis, nasal malignancies, or past endoscopic endonasal surgeries for nasal pathologies

Design outcomes

Primary

MeasureTime frame
percentage of anatomical and functional success at the end of follow-up period.Timepoint: Check anatomical success - baseline and 6 months Check functional success - baseline, 6 months

Secondary

MeasureTime frame
decrease in epiphora and pain, days for complete resolution of pain and swelling, endoscopic assessment of ostium, socioeconomic impact of treatment for acute dacryocystitisTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Shalin Shah

Divyajyot trust eye hospital

shahshalinsss@gmail.com9409306175

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026